Shanghai Henlius Biotech, Inc. Class H (2696) Income Statement

Last quarter (Q2 2024), Shanghai Henlius Biotech, Inc. Class H's total revenue was ¥1.37B, an increase of 9.82% from the same quarter last year. In Q2, Shanghai Henlius Biotech, Inc. Class H's net income was ¥193.15M. See Shanghai Henlius Biotech, Inc. Class H’s key income statements, including revenue, expenses, profit, and income.